What Makes Up A DCT At Sanofi?
Source: Clinical Leader
Merissa Govender, Global Innovation Leader at Sanofi, Lindsay Kehoe, Senior Project Manager at Clinical Trials Transformation Initiative (CTTI), and Aneta Woroniecka-Osio, DCT Strategy Development Lead at Bayer come together for Clinical Leader Live's session: Last Year’s DCT Is Today’s Clinical Trial.
In this snippet, Govender explains how the company defines a DCT and what therapeutic areas they focus on for these kinds of trials.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more